Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00GBZ
|
|||
| Former ID |
DIB014686
|
|||
| Drug Name |
CEQ-508
|
|||
| Synonyms |
CEQ-501; TkRNAis (oral, familial adenomatous polyposis/colon cancer), Cequent; TkRNAis (oral, familial adenomatous polyposis/colon cancer), Marina
Click to Show/Hide
|
|||
| Drug Type |
siRNA drug
|
|||
| Indication | Familial adenomatous polyposis [ICD-11: 2B90.Y] | Phase 1/2 | [1] | |
| Company |
Cequent Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Current Progress of siRNA/shRNA Therapeutics in Clinical Trials. Biotechnol J. 2011 September; 6(9): 1130-1146. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.